Review And Identification Of Criteria For Value Assessment Of Medication Adherence-Enhancing Interventions


Moderator: Mickaël Hiligsmann, PhD, Department of Health Services Research, School for Public Health and Primary Care, Maastricht University, Maastricht, LI, Netherlands
Speakers: Tamas Agh, MD, PhD, Syreon Research Institute, Budapest, PE, Hungary; Andrew Peterson, PharmD, PhD, FCPP, Substance Use Disorders Institute, John Wyeth Dean Emeritus, Professor of Clinical Pharmacy and Professor of Health Policy, University of the Sciences, Philadelphia, PA, USA

Group Discussions are a new, two-part content type for ISPOR events: an on demand, pre-recorded session to be released before the live conference dates, and a follow-up hour-long live discussion during the live conference dates. The expectation for attendees is that they watch the on-demand content before the meeting, and then participate in a live discussion of the on-demand sessions during the conference.

To participate in this group discussion session, please watch the on-demand session titled Review And Identification Of Criteria For Value Assessment Of Medication Adherence-Enhancing Interventions, which is available to conference registrants here. The on-demand session is presented by the ISPOR Medication Adherence and Persistence Special Interest Group and the leaders of this group will facilitate this networking session.

Medication non-adherence is prevalent across most clinical conditions causing major medical and economic challenges. Although several studies have demonstrated that medication adherence enhancing interventions (MAEIs) may improve health outcomes, existing evidence on the effectiveness of MAEIs remains of poor quality. Important policy decisions about MAEIs are therefore currently based on inadequate or suboptimal information. The Medication Adherence and Persistence Special Interest Group (MAP-SIG) is conducting a systematic evaluation of the evidence associated with MAEIs by identifying and prioritizing relevant criteria for their value assessment from the perspectives of different stakeholders. Attendees interested in medication adherence and developing consensus-based criteria to assess value of MAEIs are welcomed to join this forum. A brief presentation on the purpose of the initiative and findings of the systematic literature review on criteria for assessing MAEIs will be presented. This will be followed by an open discussion on the criteria. The attendees will be asked to: 1) share their opinions on identified criteria, 2) suggest improvements to criteria presented, and 3) recommend additional criteria. After a final list of criteria is obtained, the audience members will rank the presented criteria in order of importance, via the polling app. Lastly, the group will be asked to share their perspectives and discuss ideas on how these criteria can be used to improve medication adherence studies. Grab your lunch and join us for this informative discussion.

Conference/Value in Health Info

2020-11, ISPOR Europe 2020, Milan, Italy
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now